Cisatracúrio Kabi

Cisatracurium Besilate is a neuromuscular blocking agent used for muscle relaxation during surgical procedures. This intravenous medication is manufactured by Fresenius Kabi Pharma Portugal, Lda.

Cisatracurium Besilate is primarily used to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery. It is often administered to patients undergoing general anesthesia to ensure optimal conditions for the surgical team. This medication is commonly referred to as a non-depolarizing neuromuscular blocking agent, which helps in temporarily paralyzing muscles to prevent movement during procedures.

Cisatracurium Besilate works by blocking the action of acetylcholine at the neuromuscular junction, leading to muscle relaxation. Common effects include temporary paralysis of skeletal muscles, which is essential for surgical interventions. The duration of these effects varies depending on the dosage and individual patient factors.

Cisatracurium Besilate should be administered by healthcare professionals experienced in the use of neuromuscular blocking agents. It is crucial to monitor patients closely for any signs of adverse reactions. Patients with a history of allergies to similar medications should exercise caution. Proper storage and handling are essential to maintain the medication's efficacy.

Cisatracurium Besilate may interact with other medications that affect neuromuscular function, such as certain anesthetics and antibiotics. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and other substances that depress the central nervous system should be avoided.